CORDIS
EU research results

CORDIS

English EN
Coordination of European funding for infectious diseases research

Coordination of European funding for infectious diseases research

Objective

Infectious diseases (ID) also known as communicable diseases are one of the majorcauses of death worldwide. Every year in Europe, infectious diseases cause tens of thousands of deaths (from ECDC ‘Microbes without borders: key facts on infectious diseases in Europe’ 2007 report).
In order to address the challenges in ID and design adapted treatments, as well as diagnostic and preventive tools, the funding programmes involved in The INFECT-ERA aim to support all basic aspects of human infection biology caused by bacteria, fungi, viruses and protozoa. To that end, research addressing the cross-talk between host and pathogens, as well as the relationship between microbes’ environment and infection will be supported by Infect-ERA. In addition, this ERA-NET aims to (i) strengthen the development and improvement of innovative tools and methodologies to address infection biology as a whole and (ii) promote the integration of new tools to carry out research.
Infect-ERA consortium is comprised of 14 participants from 11 countries. It will build on the established network of National Funding Bodies that are participating in the ERA-NET of PathoGenoMics and will bring in new ones. With the accession of new partners the organization of the network will be updated. It will strongly rely on PathoGenoMics’s achievements, such as the establishment of principles and mechanisms for the evaluation of joint calls and for the management of transnational projects. Infect-ERA will therefore concentrate on funding high quality and cutting edge research through yearly Join Transnational Calls (2013-2016). It will also contribute to the European mobility initiatives and strengthen the European research by expanding the young scientist support initiated in PathoGenoMics, and facilitating the mobility of young researchers. Infect-ERA will also develop a long-term cooperation framework in infectious diseases. Infect-ERA will also enable further knowledge on intellectual property protection among scientists of funded projects.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

AGENCE NATIONALE DE LA RECHERCHE

Address

50 Avenue Daumesnil
75012 Paris

France

Activity type

Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)

EU Contribution

€ 455 925

Administrative Contact

Dalar Hamon-Arslanyan (Mrs.)

Participants (18)

Sort alphabetically

Sort by EU Contribution

Expand all

ORSZAGOS TUDOMANYOS KUTATASI ALAPPROGRAMOK IRODA

Hungary

AUTORITATEA NATIONALA PENTRU CERCETARE STIINTIFICA

Romania

FONDS ZUR FÖRDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG

Austria

EU Contribution

€ 131 021

AGENTSCHAP VOOR INNOVATIE DOOR WETENSCHAP EN TECHNOLOGIE

Belgium

STYRELSEN FOR FORSKNING OG UDDANNELSE

Denmark

MINISTRY OF HEALTH

Israel

EU Contribution

€ 143 882

NARODOWE CENTRUM NAUKI

Poland

EU Contribution

€ 19 688

NARODOWE CENTRUM BADAN I ROZWOJU

Poland

EU Contribution

€ 24 877

MINISTERIO DE ECONOMIA, INDUSTRIA Y COMPETITIVIDAD

Spain

EU Contribution

€ 252 573

INSTITUTO DE SALUD CARLOS III

Spain

EU Contribution

€ 194 633

FUNDACAO PARA A CIENCIA E A TECNOLOGIA

Portugal

EU Contribution

€ 156 915

FORSCHUNGSZENTRUM JULICH GMBH

Germany

EU Contribution

€ 228 383

Ministerul Educatiei Nationale si Cercetarii Stiintifice

Romania

MAGYAR TUDOMANYOS AKADEMIA TITKARSAGA

Hungary

EU Contribution

€ 107 521

NEMZETI KUTATASI FEJLESZTESI ES INNOVACIOS HIVATAL

Hungary

EU Contribution

€ 42 190

INNOVATIONSFONDEN

Denmark

EU Contribution

€ 53 692

AUTORITATEA NATIONALA PENTRU CERCETARE STIINTIFICA SI INOVARE

Romania

EU Contribution

€ 31 137

FONDS FLANKEREND ECONOMISCH EN INNOVATIEBELEID

Belgium

EU Contribution

€ 157 557

Project information

Grant agreement ID: 321529

Status

Closed project

  • Start date

    1 January 2013

  • End date

    31 December 2016

Funded under:

FP7-HEALTH

  • Overall budget:

    € 2 281 955,91

  • EU contribution

    € 1 999 994

Coordinated by:

AGENCE NATIONALE DE LA RECHERCHE

France